-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs022505-wetterneck-final-report-2020.pdf
January 01, 2020 - information about interactions between
different orders, allergies and adverse reactions, kidney and liver
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
March 01, 2022 - NSAIDs have increased
risk of serious gastrointestinal, liver dysfunction,
and cardiovascular adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
December 20, 2012 - clinically relevant, and highlight the need for research in final
health outcomes, particularly clinical liver
-
digital.ahrq.gov/sites/default/files/docs/publication/u18hs016970-bates-final-report-2012.pdf
January 01, 2012 - to identify ADEs,
medication allergies, comorbidities, specific lab results (e.g., renal function, liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - this caveat about the demand for donor lungs: “[It] is much
lower than the demand for kidneys and livers
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_6-user-guide-to-ocer_130129.pdf
October 30, 2012 - or more aggressive
in those with one treatment than another (i.e.,
surveillance bias, e.g., when liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
May 01, 2025 - E
Lancet (London, England) 2023;402 Suppl
1:S58
Intervention not of
interest
Khaitan
2019
Liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/myqvgr-dsW7k3eQbwj4aR4
February 01, 2013 - Primary Care–Relevant Interventions for Tobacco Use Prevention and Cessation in Children and Adolescents: A Systematic Evidence Review for the USPSTF
Primary Care–Relevant Interventions for Tobacco Use Prevention and
Cessation in Children and Adolescents: A Systematic Evidence Review
for the U.S. Preventive Services …
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/webinars/cahps-cancer-care-transcript.pdf
June 01, 2017 - cancer types, which I will read off slowly: bladder,
brain, breast, cervix, colon, esophagus, lung, liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
June 11, 2019 - Liver and
renal safety of tenofovir disoproxil fumarate in
combination with emtricitabine among African
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening
May 08, 2018 - Annual report to the nation on the status of cancer, 1975–2012, featuring the increasing incidence of liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/JcwfLrEqaaxP6DPEQvxgUs
February 18, 2020 - conditions, statin use was not associated with serious ad-
verse events such as cancer, severely elevated liver
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2022-annual-report-to-congress.pdf
January 01, 2022 - associated chronic comorbid conditions, including hypertension,
dyslipidemia, and nonalcoholic fatty liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - Specific adverse events for each drug class, such as
gastrointestinal events, cardiovascular events, and liver
-
www.ahrq.gov/sites/default/files/2024-11/becker-bix-report.pdf
January 01, 2024 - warning
-1 -0.5 0 0.5 1
CRV
Do Not Use warning
Ask a doctor or pharmacist before…
Organ system (liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol-final.pdf
October 15, 2024 - Alzheimer’s disease and other dementias, or
cognitive decline
• Side effects of treatment including liver
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopausal-symptoms-protocol.pdf
October 15, 2024 - Alzheimer’s disease and other dementias, or
cognitive decline
• Side effects of treatment including liver
-
effectivehealthcare.ahrq.gov/health-topics/lipid-metabolism-disorders
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - independently associated with bleeding risk in multivariable analyses include older age, male sex, diabetes, liver
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018646-gance-cleveland-final-report-2014.pdf
January 01, 2014 - Laboratory evaluations covered if a provider requests lipid profile, total cholesterol, glucose, or
liver